|
| Information on Skyrun Industrial Co., Ltd. |
| Skyrun Industrial Co.Limited, established in 2003, a state-controlled company (By Skyrun Corp. & High Hope) in China, specializing in developing, producing and handing raw pharmaceutical material and intermediates. We have expanded a compositive entity from initially only as a small manufacturer. We have extensive knowledge of domestic and international pharmaceutical markets. Our working range can be start from small amount in research stage to big bulk for industrial production. |
|
Skyrun Industrial Co., Ltd. also offers: (3S)-3-(tert-Butoxycarbonyl)amino-1-chloro-4-phenyl-(2S)-butanol (3S)-(-)-3-Acetamidopyrrolidine (3S)-(+)-3-Aminopyrrolidine dihydrochloride (3S)-(+)-1-Benzyl-3-aminopyrrolidine (3R-Trans)-3,4-bis(diphenylphosphino)-1-(phenylmethyl)pyrrolidine monohydrochloride (3R-Cis)-(-)-3-Isopropyl-7a-methyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one (3R,6E,10S)-6,10á-dimethyl-3-isopropyl-6-cyclodecene-1,4-dione (3R,5S,6E)-rel-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-Heptenoic acid ethyl ester (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid 1,1-dimethylethyl ester (3R,5S)-6-Chloro-3,5-dihydroxyhexanoic acid 1,1-dimethylethyl ester (3R,4S)-tert-Butyl 3-(1-ethoxyethoxy)-2-oxo-4-phenylazetidine-1-carboxylate (3R,4S)-3-Hydroxy-4-phenyl-2-azetidinone (3R,4S)-1-tert-Butoxycarbonyl-3-triethylsilyloxy-4-phenyl-2-azetidinone (3R,4S)-1-Benzoyl-3-(2-ethoxyethoxyl)-4-phenyl-2-azetidinone (3R,4S)-1-Benzoyl-3-(1-methoxy-1-methylethoxy)-4-phenyl-2-azetidinone (3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-[4-(phenylmethoxy)phenyl]-2-azetidinone (3R,4S)-1-(4-Fluorophenyl)-2-oxo-4-[4-(benzyloxy)phenyl]-3-azetidinepropanoic acid (3R,4R,5S)-4-n-acetyl(1,1-dimethylethyl)amino-5-N,N-diallylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl estermonohydrochloride (3R,4R,5S)-4-acetylamino-5-azido-3-(1-ethylpropoxy)cyclohex-1-enecarboxylic acid ethyl ester (3R,4R)-4-Acetoxy-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]-2-azetidinone (3R,4R)-3-Hydroxy-5-[(E)-1-propenyl]cyclo[l-leu-L-abu-sar-N-methyl-L-leu-L-val-N-methyl-L-leu-L-ala-D-ala-N-methyl-L-leu-N-methyl-L-leu-N-methyl-L-val-] (3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol (3R)-5-Oxo-3-[(triethylsilyl)oxy]-1-cyclopentene-1-heptanoic acid methyl ester (3R)-3-Aminobutanoic acid ethyl ester (3R)-3-Aminobutan-1-ol (3R)-3-Amino-1,2,3,4-tetrahydrocarbazole (3R)-3-(tert-Butyldimethylsilyloxy)glutaric acid-1-((R)-(-)-mandelic acid ester (3R)-(-)-3-Aminopyrrolidine dihydrochloride (3R)-(+)-Aminopyrrolidine (3R)-(+)-3-(Dimethylamino)pyrrolidine (3E,5E)-5-(1,3,3-trimethyl-2-indolinylidene)-3-penten-2-one (3beta,4alpha,16alpha)-3,16-dihydroxy-23-oxoolean-12-en-28-oic acid (3aS,4R,5S,6aR)-(+)-Hexahydro-5-hydroxy-4-(hydroxymethyl)-2H-cyclopenta[b]furan-2-one (3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione (3aR,4S,6R,6aS)-6-[[6-chloro-5-nitro-2-(propylthio)-4-pyrimidinyl]amino]tetrahydro-2,2-dimethyl-4H-Cyclopenta-1,3-dioxol-4-ol (3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol (3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol (3aR,4R,5R,6aS)-5-(benzoyloxy)hexahydro-4-[(1E)-3-oxo-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-2-one (3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-2-one (3-Trifluoromethylphenyl)-carbamic acid tert-butyl ester (3-Trifluoromethyl-alpha-toluenesulfonyl)acetic acid (3-Sinapoyl)fructofuranosyl-(6-sinapoyl)glucopyranoside (3-Phenoxy-phenyl)-hydrazine (3-Methylaminopropyl)-trimethoxysilane (3-Methyl-2-thienyl)methylamine (3-Methoxy-benzyl)-(2-methoxy-ethyl)-amine (3-Mercaptopropyl)methyldimethoxysilane (3-Hydroxy-3H-1,2,3-triazolo(4,5-b)pyridinato-o)tri-1-pyrrolidinylphosphonium hexafluorophosphate (3-Glycidyloxypropyl)triethoxysilane
|
|
